DK3630093T3 - Behandling af sygdomme associeret med en dysregulering af mtor-vejen - Google Patents

Behandling af sygdomme associeret med en dysregulering af mtor-vejen

Info

Publication number
DK3630093T3
DK3630093T3 DK18733182.2T DK18733182T DK3630093T3 DK 3630093 T3 DK3630093 T3 DK 3630093T3 DK 18733182 T DK18733182 T DK 18733182T DK 3630093 T3 DK3630093 T3 DK 3630093T3
Authority
DK
Denmark
Prior art keywords
dystrulation
treatment
diseases associated
mtor pathway
mtor
Prior art date
Application number
DK18733182.2T
Other languages
English (en)
Inventor
Marc Verleye
Guern Marie-Emmanuelle Le
Véronique Riban
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Application granted granted Critical
Publication of DK3630093T3 publication Critical patent/DK3630093T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18733182.2T 2017-05-30 2018-05-30 Behandling af sygdomme associeret med en dysregulering af mtor-vejen DK3630093T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305620 2017-05-30
PCT/EP2018/064282 WO2018220068A1 (en) 2017-05-30 2018-05-30 TREATMENT OF DISEASES ASSOCIATED WITH A DYSREGULATION OF THE mTOR PATHWAY

Publications (1)

Publication Number Publication Date
DK3630093T3 true DK3630093T3 (da) 2025-10-20

Family

ID=59054052

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18733182.2T DK3630093T3 (da) 2017-05-30 2018-05-30 Behandling af sygdomme associeret med en dysregulering af mtor-vejen

Country Status (8)

Country Link
US (1) US20200179335A1 (da)
EP (1) EP3630093B1 (da)
JP (1) JP7395358B2 (da)
CA (1) CA3065417A1 (da)
DK (1) DK3630093T3 (da)
ES (1) ES3053709T3 (da)
PL (1) PL3630093T3 (da)
WO (1) WO2018220068A1 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795893A (fr) 1972-02-28 1973-06-18 Unicler Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique
EP1546369A4 (en) * 2002-08-12 2007-01-17 Univ Michigan DIAGNOSIS AND TREATMENT OF DISEASES THROUGH DEFECTS IN THE TUBEROUS SKLEROSEPFAD
EP2201950B1 (en) 2008-12-08 2016-11-16 Biocodex Compounds and methods for treating autism spectrum disorders
WO2014115764A1 (ja) 2013-01-25 2014-07-31 国立大学法人岡山大学 乳酸脱水素酵素阻害剤およびそれを含有する医薬品
GB2531281A (en) * 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy

Also Published As

Publication number Publication date
CA3065417A1 (en) 2018-12-06
ES3053709T3 (en) 2026-01-26
PL3630093T3 (pl) 2025-12-08
JP7395358B2 (ja) 2023-12-11
US20200179335A1 (en) 2020-06-11
EP3630093A1 (en) 2020-04-08
WO2018220068A1 (en) 2018-12-06
EP3630093B1 (en) 2025-08-20
JP2020521782A (ja) 2020-07-27

Similar Documents

Publication Publication Date Title
DK3728271T3 (da) Makrocykliske forbindelser til behandling af sygdomme
HUE064141T2 (hu) Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
PL3600309T3 (pl) Skojarzenia terapeutyczne do leczenia chorób wątroby
DK3169328T3 (da) Quinolinderivater til behandling af inflammationssygdomme
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3777855T3 (da) Fremgangsmåder til behandling af fibrotiske sygdomme
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3865484T3 (da) Pde9-hæmmer med imidazopyrazinon-rygrad til behandling af perifere sygdomme
DK3548061T3 (da) Behandling af neurologiske sygdomme
DK3097085T3 (da) Benzoxazinonderivater til behandling af hudsygdomme
DK3612208T3 (da) Coversin til behandlingen af autoimmune sygdomme med blisterdannelse
EP3735463A4 (en) Cytotoxicity-inducing therapeutic agent
DK3419622T3 (da) Behandling af neurodegenerativ øjensygdom med pridopidin
DK3192524T3 (da) Hgf præparat egnet til behandling af neurologiske lidelser
DK3576738T3 (da) Gaboxadolmonohydrat i behandling af tinnitus
DK3408265T3 (da) Terapeutiske forbindelser
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
IL259486A (en) Agents for the treatment of diseases associated with undesired cell proliferation
IL262851A (en) Combination prime: boost therapy
DK3439661T3 (da) Fremgangsmåder til behandling af øjenlidelser
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
EP3493821A4 (en) METHOD OF TREATING THE RESPIRATORY TRACT